Novel application of Danhong blood stasis dispersing composition
A technology of Danhong removing blood stasis and composition, which is applied in the application field of Danhong removing blood stasis composition as a histone deacetylase agonist, and achieves the effects of fast onset time and exact effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0028] Example 1: Study on the effect of DHK in regulating SIRT1 / NF-κB signaling pathway
[0029] 1. Experimental animals: SPF grade SD rats; half male and half male; 30 in total; 250-280g
[0030] 2. Experimental drugs and instruments:
[0031] Physiological saline (Foshan Shuanghe Pharmaceutical Co., Ltd.), Xylazine injection (Jilin Huamu Animal Health Products Co., Ltd.), Pentobarbital Sodium (German Merck), Ceftriaxone Sodium for Injection (Shenzhen Li Jian Pharmaceutical Co., Ltd.), 2% lidocaine hydrochloride (Hubei Tianyao Pharmaceutical Co., Ltd.), rat CRP ELISA kit (Nanjing Jiancheng Company), rat IL-1β ELISA kit (U.S. eBioscience company), rat TNF-α ELISA kit (Lianke Biotechnology Co., Ltd.), rat PAI-1 ELISA kit (British Abcam), rat tPA ELISA kit (British Abcam), BCA protein detection kit (Comverse Century Co., Ltd.) , Anti-SIRT1 antibody (abcam company), Anti-Akt antibody (CST company), Anti-p-Akt antibody (CST company), Anti-p65 antibody (CST company), Anti-p-p65 antibod...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap